文献速递认知障碍与谵妄多重用药

抗胆碱能负荷降低阈值与痴呆行为心理症状改善

Threshold for a Reduction in Anticholinergic Burden to Decrease Behavioral and Psychological Symptoms of Dementia.
PubMed 文献 · J Am Med Dir Assoc · 2018-11-28

BACKGROUND: A high anticholinergic burden (AB) is associated with the occurrence of behavioral and psychological symptoms (BPSDs), which are frequent in dementia.…

要点

  • 痴呆老年患者抗胆碱能负荷降低2分可改善中度行为心理症状的频率与严重度。
  • 负荷降低3分与职业扰乱度评分临床显著改善相关。
  • 应尽量避免高抗胆碱能负荷药物,优先选择低负荷药物。

核心结论

  • 在伴有行为心理症状的痴呆老年患者中,根据评估量表的不同,抗胆碱能负荷的小幅降低与中度症状的频率、严重度和扰乱度下降相关。

主要发现

  • 使用ADS量表,中度行为心理症状患者抗胆碱能负荷降低2分与NPI-NH频率×严重度评分临床显著改善相关(6.34,95%CI 4.54-8.14)。
  • 使用ADS量表,抗胆碱能负荷降低3分与职业扰乱度评分临床显著改善相关(4.26,95%CI 3.11-5.41)。

关键数值与推荐

  • 行为心理症状的临床显著改善定义为NPI-NH问卷频率×严重度评分降低4分。
  • 抗胆碱能负荷分别用ADS、ACB和ARS三种量表评估。

临床怎么用

  • 在痴呆老年患者中,应尽可能避免高抗胆碱能负荷药物,优先选择低负荷药物。
  • 因行为心理症状住院的痴呆患者,建议采用标准化方法分析和降低抗胆碱能负荷。

局限性

  • 不同抗胆碱能负荷评估量表之间存在异质性,限制了负荷降低对行为心理症状影响的推广。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A high anticholinergic burden (AB) is associated with the occurrence of behavioral and psychological symptoms (BPSDs), which are frequent in dementia. OBJECTIVES: Our aim was to determine the threshold for a reduction in AB that would lead to a clinically significant improvement in BPSDs (in terms of frequency, severity, and disruptiveness). DESIGN: A single-center prospective study. SETTINGS: Dedicated geriatric care unit specializing in the management of patients with dementia. PARTICIPANTS: The study involved older patients with dementia, hospitalized for management of BPSDs. METHODS: One hundred forty-seven patients were included (mean age = 84.1 ± 5.2 years). The AB was assessed using 3 scales, namely, the Anticholinergic Drug Scale (ADS), the Anticholinergic Cognitive Burden scale (ACB), and the Anticholinergic Risk Scale (ARS). A clinically significant improvement in BPSDs was defined as a reduction of 4 points in the frequency × severity (F×S) score of the Neuropsychiatric Inventory-Nursing Home (NPI-NH) questionnaire. The threshold for a reduction in AB that corresponded to a clinically significant improvement in BPSDs was determined by multiple linear regression. RESULTS: One hundred forty-seven patients were included (mean age = 84.1 ± 5.2 years). Using the ADS, a reduction of 2 points in AB in patients with moderate-intensity BPSDs was associated with a clinically significant improvement in the F×S score of the NPI-NH [6.34, 95% confidence interval (CI) 4.54-8.14], and a reduction of 3 points was associated with a clinically significant improvement in the occupational disruptiveness score (4.26, 95% CI 3.11-5.41). CONCLUSIONS/IMPLICATIONS: In older patients with dementia presenting BPSDs, the risk-benefit ratio of anticholinergic drugs is debatable and, where possible, drugs with a lower AB would be preferable. Because BPSDs are a frequent cause of hospitalization, a standardized approach to analysis and reduction of AB is warranted in this population. Depending on the scale used to assess anticholinergic burden (AB), a small reduction in AB is associated with a decrease in frequency, severity, and disruptiveness of moderate-intensity BPSDs. Drugs with a high AB should be avoided where possible in older patients with dementia, and drugs with a lower AB would be preferable. Heterogeneity between the assessment scales for AB precludes generalization of the impact of a reduction in AB on BPSDs.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Jaïdi Y, Guilloteau A, Nonnonhou V, et al. Threshold for a Reduction in Anticholinergic Burden to Decrease Behavioral and Psychological Symptoms of Dementia. J Am Med Dir Assoc. 2018. PMID: 30503588. doi:10.1016/j.jamda.2018.10.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。